DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Adkins D, Ley J, Neupane P. et al.
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.
Lancet Oncol 2019;
20 (09) 1295-1305
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.